Item 1A. Risk Factors

There are no material changes to the risk factors previously disclosed in our 2023 Form 10-K in response to Item 1A. to Part I of Form 10-K. See also Part I Item 2., Management's Discussion and Analysis of Financial Condition and Results of Operations for additional information regarding supply chain and foreign currency exchange rate risks.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table sets forth the shares repurchased during each fiscal month during the third quarter of 2024:


Fiscal Month 2024	Total number of shares purchased	Average price paid per share		Total number of shares purchased as part of publicly announced plans or programs (a)	Maximum dollar value of shares that may yet be purchased under the plans or programs (in Millions) (a)
July 1 - August 4	214,150	$	394.43	214,150	$	971.7
August 5 - September 1	67,899	$	415.70	67,899	$	943.5
September 2 - September 29	60,936	$	428.36	60,936	$	917.4
Total	342,985	$	404.67	342,985

(a) On April 23, 2024, the Company’s Board of Directors authorized a new stock repurchase program to repurchase up to $1.25 billion of the Company’s common stock. The authorized stock repurchase program does not have a stated expiration date.

Previous: Item 4. Controls and Procedures · Next: Item 5. Other Information